BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19089326)

  • 1. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of PDEs and their regulation.
    Omori K; Kotera J
    Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide specific phosphodiesterases of Leishmania major.
    Johner A; Kunz S; Linder M; Shakur Y; Seebeck T
    BMC Microbiol; 2006 Mar; 6():25. PubMed ID: 16522215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
    Lugnier C
    Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages.
    Bender AT; Beavo JA
    Neurochem Int; 2004 Nov; 45(6):853-7. PubMed ID: 15312979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R; Kumar G; Kumar RS
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains.
    Beltman J; Becker DE; Butt E; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
    Mol Pharmacol; 1995 Feb; 47(2):330-9. PubMed ID: 7870041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour.
    Kleppisch T; Feil R
    Handb Exp Pharmacol; 2009; (191):549-79. PubMed ID: 19089345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.
    Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J
    J Comp Neurol; 2003 Dec; 467(4):566-80. PubMed ID: 14624489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular genetics of the phosphodiesterases (PDEs).
    Azevedo MF; Faucz FR; Bimpaki E; Horvath A; Levy I; de Alexandre RB; Ahmad F; Manganiello V; Stratakis CA
    Endocr Rev; 2014 Apr; 35(2):195-233. PubMed ID: 24311737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation.
    Baxendale RW; Fraser LR
    Mol Reprod Dev; 2005 Aug; 71(4):495-508. PubMed ID: 15856425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.
    Xu Y; Zhang HT; O'Donnell JM
    Handb Exp Pharmacol; 2011; (204):447-85. PubMed ID: 21695652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterases regulate airway smooth muscle function in health and disease.
    Krymskaya VP; Panettieri RA
    Curr Top Dev Biol; 2007; 79():61-74. PubMed ID: 17498547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide-specific phosphodiesterases of Plasmodium falciparum: PfPDEalpha, a non-essential cGMP-specific PDE that is an integral membrane protein.
    Wentzinger L; Bopp S; Tenor H; Klar J; Brun R; Beck HP; Seebeck T
    Int J Parasitol; 2008 Dec; 38(14):1625-37. PubMed ID: 18590734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase regulation of nitric oxide signaling.
    Kass DA; Takimoto E; Nagayama T; Champion HC
    Cardiovasc Res; 2007 Jul; 75(2):303-14. PubMed ID: 17467673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
    Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
    J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterases in neurodegenerative disorders.
    Bollen E; Prickaerts J
    IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.